Johnson Financial Group LLC (Colorado)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
6,650
-342
-5% -$73.6K 0.09% 60
2026
Q1
$1.52M Buy
6,992
+2,609
+60% +$579K 0.1% 45
2025
Q4
$1M Buy
4,383
+2,104
+92% +$479K 0.06% 52
2025
Q3
$528K Hold
2,279
0.05% 47
2025
Q2
$423K Sell
2,279
-170
-7% -$31.6K 0.04% 49
2025
Q1
$513K Buy
+2,449
New +$476K 0.05% 48
2022
Q2
Sell
-1,253
Closed -$203K 51
2022
Q1
$203K Buy
+1,253
New +$182K 0.03% 46
2018
Q1
$327K Buy
+3,457
New +$380K 0.27% 32

Other funds holding ABBV

Johnson Financial Group LLC (Colorado)'s ABBV Position: Q2 2026 in Review

Johnson Financial Group LLC (Colorado) reduced its AbbVie (ABBV) stake by 4.9% in Q2 2026, selling an estimated $73.6K and leaving 6,650 shares worth $1.67M. The position accounts for 0.09% of the portfolio, ranked #60.

Johnson Financial Group LLC (Colorado) first reported a position in ABBV in Q1 2018 and has held it in 8 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Johnson Financial Group LLC (Colorado) held 6,650 shares of AbbVie worth $1.67M as of Q2 2026.
  • Johnson Financial Group LLC (Colorado) sold 342 AbbVie shares in Q2 2026, an estimated $73.6K.
  • AbbVie made up 0.09% of Johnson Financial Group LLC (Colorado)'s portfolio in Q2 2026, its #60 holding.
  • Johnson Financial Group LLC (Colorado) first reported a position in AbbVie in Q1 2018 and has held it in 8 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q2 2026, filed 6 Aug 2026.